A family of institutions
working together on the Can Ruti Campus
 

News

03/12/2021

952,000 euros for the IGTP Spin-Off Biointaxis to develop gene therapy for Friedriech’s ataxia

Biointaxis, spin-off company from the Germans Trias i Pujol Research Institute (IGTP) has closed a financing round of 952,000 euros on the Capital Cell Platform. The company will use the investment to advance the pre-clinical research for their treatment for Friedriech's ataxia, a rare progressive degenerative disease. The studies aim to validate the safety of their treatment.

Events

Monday 24 January

Cytometry

IGTP Core Facility Seminars
Marco A Fernández
Head of the IGTP Cytometry Facility

Research in Figures

925

Contracted and affiliated research staff

270

Active projects

946

Publications 2020

36

Research Groups (IGTP CERCA Centre)

34

Active Patent Families

627

Active clinical trials

Shortcuts

IGTP Corporate Video

See our video here

GCAT Project

50,000 volunteers participating in one biomedical research project to enable researchers to answer vital questions about our health and improve treatments